|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Nurix Garners $3,100,000 New Funding Round
|
VentureDeal |
05/17/12 |
San Francisco
|
|
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies
|
Luke Timmerman |
05/16/12 |
National
|
|
Aragon Pharmaceuticals Obtains $42,000,000 Series C Financing Round
|
VentureDeal |
03/06/12 |
San Diego
|
|
Genentech Pours $95M Into Constellation’s Drug Platform
|
Arlene Weintraub |
01/17/12 |
Boston
|
|
Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better
|
Luke Timmerman |
10/24/11 |
National
|
|
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/06/11 |
Seattle
|
|
Immune Design Rakes In Another $11M From Prior VC Round
|
Luke Timmerman |
10/05/11 |
Seattle
|
|
Peloton Therapeutics Lands $18,000,000 Series A Financing Round
|
VentureDeal |
07/27/11 |
San Francisco
|
|
Cyterix Develops New Twist on an Old Idea, With ‘Smart Bomb’ Cancer Drugs
|
Luke Timmerman |
06/22/11 |
San Francisco
|
|
Constellation Pharma Raises More Money and Further Defines Pipeline
|
Arlene Weintraub |
06/17/11 |
Boston
|
|
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News
|
Erin Kutz |
06/10/11 |
Boston
|
|
General Compression Pulls In $20.4M, Constellation Nabs $15M, PolyRemedy Wraps Up $20M, & More Boston-Area Deals News
|
Erin Kutz |
06/08/11 |
Boston
|
|
Cyterix Pharmaceuticals Receives $9,200,000 Series A Funding Round
|
VentureDeal |
06/08/11 |
San Francisco
|
|
Cyterix Raises $9.2M for Cancer Drugs
|
Luke Timmerman |
06/07/11 |
San Francisco
|
|
Constellation Pharma Raises $15M for Epigenetic Drugs
|
Gregory T. Huang |
06/06/11 |
Boston
|
|
Constellation Pharmaceuticals Garners $15,000,000 Series B Funding
|
VentureDeal |
06/06/11 |
Boston
|
|
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO
|
Luke Timmerman |
04/27/11 |
Seattle
|
|
Tom Maniatis, Molecular Biology Pioneer, Seeks to Help Build a Kendall Square in NYC
|
Luke Timmerman |
04/05/11 |
New York
|
|
VBI Progressing with Vaccines That Don’t Require Refrigeration
|
Ryan McBride |
03/24/11 |
Boston
|
|
Immune Design Pockets $32M, InDi Nails $10M, SonoSite Looks Inside My Carotids, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/29/10 |
Seattle
|
|
Immune Design Nabs $32M for Targeted Vaccines
|
Luke Timmerman |
07/26/10 |
Seattle
|
|
Immune Design Obtains $32,000,000 Series B Funding Round
|
VentureDeal |
07/26/10 |
Seattle
|
|
The Mission Bay Biotech Cluster: Antibodies, RNAi, Biofuels, & More
|
Luke Timmerman |
06/29/10 |
San Francisco
|
|
Igenica Lands $24,000,000 Series B Financing Round
|
VentureDeal |
06/11/10 |
San Francisco
|
|
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News
|
Erin Kutz |
06/04/10 |
Boston
|
|
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma
|
Ryan McBride |
06/02/10 |
Boston
|
|
Constellation Pharmaceuticals Lands $22,000,000 Series B Funding Round
|
VentureDeal |
06/02/10 |
Boston
|
|
Aragon Pharmaceuticals Receives $22,000,000 Series B Financing
|
VentureDeal |
04/23/10 |
San Diego
|
|
Aragon Pharmaceuticals Moves to First Clinical Trial with $22M
|
Ryan McBride |
04/22/10 |
San Diego
|
|
Selecta Biosciences, a Bob Langer Creation, Raises $15M For Nanoparticle Vaccines
|
Luke Timmerman |
04/05/10 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.